Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1980 1
1987 4
1988 3
1989 4
1991 2
1992 7
1993 6
1994 7
1995 2
1996 4
1997 9
1998 6
1999 10
2000 4
2001 9
2002 9
2003 11
2004 8
2005 12
2006 10
2007 13
2008 14
2009 21
2010 15
2011 11
2012 14
2013 21
2014 19
2015 23
2016 24
2017 28
2018 24
2019 19
2020 27
2021 19
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Radiopharmaceuticals, 2Fadministration, 5BMeSH
Page 1
Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Yam JC, et al. Ophthalmology. 2019 Jan;126(1):113-124. doi: 10.1016/j.ophtha.2018.05.029. Epub 2018 Jul 6. Ophthalmology. 2019. PMID: 30514630 Clinical Trial.

RESULTS: After 1 year, the mean SE change was -0.270.61 D, -0.460.45 D, -0.590.61 D, and -0.810.53 D in the 0.05%, 0.025%, and 0.01% atropine groups, and placebo groups, respectively (P < 0.001), with a respective mean increase in AL of 0.200.25 mm, 0.290.20 mm, 0.360.29 mm, a

…
RESULTS: After 1 year, the mean SE change was -0.270.61 D, -0.460.45 D, -0.590.61 D, and -0.810.53 D in the 0.05%, 0.025%, and 0.01% atropin …
Intensity-modulated brachytherapy for vaginal cancer.
Joya M, Nedaie HA, Geraily G, Seiri M, Ghorbani M, Sheikhzadeh P. Joya M, et al. Radiol Phys Technol. 2022 Dec;15(4):387-397. doi: 10.1007/s12194-022-00680-4. Epub 2022 Sep 7. Radiol Phys Technol. 2022. PMID: 36069978
Static IMBT decreased the D(2cc) for the rectum and bladder by 11.69 and 9.29% using the (60)Co source and by 22.21 and 17.71% using the (192)Ir source, respectively. In contrast, absorbed dose parameters (D(5), D(90), and D(100)) for the target in the three techniques sho …
Static IMBT decreased the D(2cc) for the rectum and bladder by 11.69 and 9.29% using the (60)Co source and by 22.21 and 17.71% using …
Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
Chai-Adisaksopha C, Nevitt SJ, Simpson ML, Janbain M, Konkle BA. Chai-Adisaksopha C, et al. Cochrane Database Syst Rev. 2017 Sep 25;9(9):CD011441. doi: 10.1002/14651858.CD011441.pub2. Cochrane Database Syst Rev. 2017. PMID: 28944952 Free PMC article. Review.
The meta-analysis did not conclusively demonstrate significant benefit of prophylaxis on health-related quality of life as measured by Haem-A-QoL score, EQ-5D total score and utility score, EQ-5D VAS and SF-36 physical summary and mental summary score (low quality e …
The meta-analysis did not conclusively demonstrate significant benefit of prophylaxis on health-related quality of life as measured by Haem- …
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
Health-related quality of life and willingness to pay measurement among patients on warfarin in Thailand.
Kulthanachairojana N, Kangwanrattanakul K, Khongmee T, Pawasan N, Chityam S, Pornwattanakavee S. Kulthanachairojana N, et al. J Pharm Policy Pract. 2023 Oct 30;16(1):130. doi: 10.1186/s40545-023-00632-2. J Pharm Policy Pract. 2023. PMID: 37904238 Free PMC article.
BACKGROUND: Complex dosage regimens and the high incidence of adverse events associated with warfarin therapy can affect the health-related quality of life (HRQoL) and willingness to pay (WTP) among patients on warfarin. ...CONCLUSIONS: Thai patients on warfarin have lower …
BACKGROUND: Complex dosage regimens and the high incidence of adverse events associated with warfarin therapy can affect the health-r …
Cost-effectiveness of Lumbar Epidural Steroid Injections.
Carreon LY, Bratcher KR, Ammous F, Glassman SD. Carreon LY, et al. Spine (Phila Pa 1976). 2018 Jan 1;43(1):35-40. doi: 10.1097/BRS.0000000000000989. Spine (Phila Pa 1976). 2018. PMID: 25996536
METHODS: Patients who had received LESI between June 2012 and July 2013 with EuroQOL-5D (EQ-5D) scores available before and after LESIs but before any surgical intervention were identified. ...Quality-adjusted life-years (QALYs) were calculated using the EQ-5D …
METHODS: Patients who had received LESI between June 2012 and July 2013 with EuroQOL-5D (EQ-5D) scores available before and af …
Low dose naloxone for pruritus in systemic sclerosis: Case series and literature review.
Meridor K, Berookhim J, Levy Y. Meridor K, et al. Medicine (Baltimore). 2022 Jan 28;101(4):e28653. doi: 10.1097/MD.0000000000028653. Medicine (Baltimore). 2022. PMID: 35089206 Free PMC article. Review.
PATIENT CONCERNS AND DIAGNOSIS: We describe 4 female patients with systemic sclerosis suffering from severe pruritus, with an average 5D-itch score of 22.75. INTERVENTION AND OUTCOMES: Low-dose oral naloxone was initiated, followed by a significant improvement in th …
PATIENT CONCERNS AND DIAGNOSIS: We describe 4 female patients with systemic sclerosis suffering from severe pruritus, with an average 5D …
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study.
Nilsson S, Cislo P, Sartor O, Vogelzang NJ, Coleman RE, O'Sullivan JM, Reuning-Scherer J, Shan M, Zhan L, Parker C. Nilsson S, et al. Ann Oncol. 2016 May;27(5):868-74. doi: 10.1093/annonc/mdw065. Epub 2016 Feb 23. Ann Oncol. 2016. PMID: 26912557 Free PMC article. Clinical Trial.
ALSYMPCA included prospective measurements of health-related quality of life (QOL) using two validated instruments: the general EuroQoL 5D (EQ-5D) and the disease-specific Functional Assessment of Cancer Therapy-Prostate (FACT-P). ...Treatment was a significant pred …
ALSYMPCA included prospective measurements of health-related quality of life (QOL) using two validated instruments: the general EuroQoL 5 …
The role of calcium and non calcium-based phosphate binders in chronic kidney disease.
Elder GJ, Center J. Elder GJ, et al. Nephrology (Carlton). 2017 Mar;22 Suppl 2:42-46. doi: 10.1111/nep.13031. Nephrology (Carlton). 2017. PMID: 28429551 Review.
In general, it seems prudent to avoid prescribing calcium-based drugs to patients who are pre-dialysis, and to use non-CBBs preferentially in CKD stage 5D. Current draft Kidney Disease Improving Global Outcomes guidelines suggest that CBB dosage be minimized in CKD …
In general, it seems prudent to avoid prescribing calcium-based drugs to patients who are pre-dialysis, and to use non-CBBs preferentially i …
Feeding an amino acid-formulated milk replacer for Holstein calves during 2 time periods.
Liu T, Hultquist K, Froehlich K, Casper DP. Liu T, et al. J Dairy Sci. 2020 Nov;103(11):10108-10121. doi: 10.3168/jds.2020-18529. Epub 2020 Sep 10. J Dairy Sci. 2020. PMID: 32921466 Free article.
The 56-d objective was to determine if the hypothesis that an EAA MR formulated to the specific EAA concentrations of a 24% CP MR, but reducing CP to 22 (22AA) compared with a standard 22% CP MR would result in similar or enhanced growth performance, while reducing …
The 56-d objective was to determine if the hypothesis that an EAA MR formulated to the specific EAA concentrations of a 24% CP MR, but reduc …
389 results